ArticleACS omega2022
Fe/Co-MOF Nanocatalysts: Greener Chemistry Approach for the Removal of Toxic Metals and Catalytic Applications.
Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Article
- Co-BDC MOF/Graphene Nanohybrid as an Efficient Electrode Material for High-Performance Supercapacitors.ACS omega · 2026Article
- Aluminium MOF as a selective sensor for atrazine with docking and computational insight.RSC advances · 2026Article
- Synthesis and COMembranes · 2025Article
- Development of borated mesoporous zirconia nanocatalyst for the green synthesis of hydroquinone diacetate.Scientific reports · 2025Article
- Efficient Photocatalytic Degradation of Malachite Green and Cr(VI) Using Co-MOF and Bacterial Cellulose@Co-MOF Biocomposite: A Green Approach.ACS omega · 2025Article
- Heavy metal pollution in aquatic environments and removal using highly efficient bimetallic metal-organic framework adsorbents.RSC advances · 2025Review
- Metal-organic framework-derived nanoflower and nanoflake metal oxides as electrocatalysts for methanol oxidation.RSC advances · 2024Article
- Article
- A comparative study of α-Ni(OH)RSC advances · 2024Article
- Rational Construction of MOF-Derived Porous ZnTiOACS omega · 2023Article
- Environmental Potential of Carbonized MOF-5/PANI Composites for Pesticide, Dye, and Metal Cations-Can They Actually Retain Them All?Polymers · 2023Article
- Fe-Based Metal Organic Frameworks (Fe-MOFs) for Bio-Related Applications.Pharmaceutics · 2023Review
- Role of nanohybrid NiO-FeHeliyon · 2023Article
- Synthesis of a New Co Metal-Organic Framework Assembled from 5,10,15,20-Tetrakis((pyridin-4-yl) phenyl)porphyrin "Co-MTPhPyP" and Its Application to the Removal of Heavy Metal Ions.Molecules (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study describes the preparation of new bimetallic (Fe/Co)-organic framework (Bi-MOF) nanocatalysts with different percentages of iron/cobalt for their use and reuse in adsorption, antibacterial, antioxidant, and catalytic applications following the principles of green chemistry. The prepared catalysts were characterized using several techniques, including X-ray powder diffraction, Fourier transform infrared spectroscopy, transmission electron microscopy, and scanning electron microscopy. These techniques proved the formation of MOFs, and the average crystallite sizes were 25.3-53.1, 27.6-67.2, 3.0-18.9, 3.0-12.9, and 3.0-23.6 nm for the Fe-MOF, Co-MOF, 10%Fe:90%Co-MOF, 50%Fe:50%Co-MOF, and 90%Fe:10%Co-MOF samples, respectively. The nanoscale (Fe/Co) Bi-MOF catalysts as efficient heterogeneous solid catalysts showed high catalytic activity with excellent yields and short reaction times in the catalytic reactions of quinoxaline and dibenzoxanthene compounds, in addition to their antioxidant and antibacterial activities. Furthermore, the nanoscale (Fe/Co) Bi-MOF catalysts efficiently removed toxic metal pollutants (Pb
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.